Wegovy monthly dosage and what it actually costs in the UK

How the monthly dosage schedule shapes the price you'll see quoted

Wegovy (semaglutide, by Novo Nordisk) is titrated over time. The licensed UK pathway moves through 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with each step lasting roughly four weeks before the prescriber considers moving up. A newer, higher dose of 7.2 mg (approved by the MHRA in April 2026) is now also available for eligible adults, giving a maximum maintenance option that approaches tirzepatide results in trials. You can read more about the full treatment picture on our Wegovy overview page.

The practical consequence for pricing is straightforward: because each monthly supply corresponds to a specific dose, and because different doses cost different amounts to source and dispense, what you pay at month two is not necessarily what you pay at month six. Some providers quote a single headline figure (usually the starter or mid-range dose) without making this obvious. Whether the price of Wegovy increases with dosage depends on the pharmacy, but the short answer is: often yes, because the medicine itself costs more at higher strengths.

The NHS confirms that Wegovy is a prescription-only medicine requiring clinical oversight; its patient information page for semaglutide sets out what treatment involves. No legitimate UK pharmacy can supply it without a valid prescription from a qualified prescriber.

What a quoted monthly price often leaves out

A number sitting on a product page rarely tells the whole story. Across the private market, providers may charge separately for the initial consultation, the prescription itself, delivery on each order, and any clinical review needed before a dose increase. Some require a membership fee to access their lower advertised price. When you add those up across a full titration course, a cheap-looking per-pen figure can become a materially higher total.

It is also worth knowing that clinical reviews are not optional extras in a responsible service. Before any dose increase, a prescriber should check that you are tolerating the current dose, that your weight loss is proceeding appropriately, and that nothing has changed clinically to affect suitability. That review has a cost to provide properly, and providers who appear not to charge for it are pricing it somewhere else, or not doing it at all.

Our guide to the average monthly cost of Wegovy breaks this down further if you want to compare how different pricing structures add up over a full course. And for a broader look at what drives private prices for this medicine, our Wegovy price page covers the market context in detail.

What nume's pricing actually includes, and why we're not the cheapest

We are transparent about one thing: price alone is not where we compete. Our single monthly price covers the clinical consultation, the prescription, the medicine, and next-working-day DPD delivery, tracked to your door. There are no separate fees for aftercare or for the clinical review that happens before every repeat order. That is deliberate, because stripping those things out to lower a headline number produces a service that is cheaper in price and thinner in safety.

Every consultation at nume is read the same day by a GPhC-registered Independent Prescriber. Not software, not a triage form that goes nowhere. A clinician reviews your answers, checks your weight evidence, and approves supply only if the clinical picture supports it. Our GPhC pharmacy registration (number 9012878, verifiable directly at the GPhC register) confirms we are a regulated dispensing pharmacy, not a referral service.

If you want to explore what structured monthly payment options look like, our Wegovy pay-monthly page explains how some patients approach the cost, and our page on Wegovy monthly cost sets out what you can realistically expect to spend at each stage of treatment. Current treatment pricing is shown on our treatments page rather than in body copy, because prices reflect your specific dose and clinical needs.

Why 'cheapest' is the wrong test for a prescription medicine

A small saving per month is not the right measure when the medicine in question is a prescription-only injectable that has been the target of widespread counterfeiting. The MHRA has repeatedly warned the public about fake weight-loss pens sold online, some containing insulin rather than semaglutide, with serious consequences. In 2025 alone, enforcement operations seized approximately 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million. If a price looks far below the private market range, that gap has to come from somewhere.

The safe route is a GPhC-registered pharmacy, a legitimate supply chain, and a prescriber who has actually assessed you. Anything offered without a clinical assessment, or from a seller you cannot verify on the regulator's register, is a different product and a different risk. The MHRA's Yellow Card scheme exists partly for reporting suspect sellers, and we would encourage anyone who comes across them to use it.

For a realistic sense of what the monthly cost of treatment looks like across the full course, our guide to monthly weight loss on Wegovy puts the numbers in clinical context, what the evidence shows, and what a realistic timeline looks like alongside the investment. You can also read more about who we are and the clinical team that reviews every order. If you have specific questions before starting, our support team is available seven days a week.